/ EN

Xuebin Liao, Ph.D.

(Summary description)Scientific Founder in immunotherapy</br></br>
</br></br></br></br></br></br></br></br></br>

*****
Xuebin Liao obtained his B.S. degree from Peking University in 1995. Then he did his Ph.D work on natural product synthesis with Prof. James M. Cook at the University of Wisconsin at Milwaukee from 1998-2004. After that, from 2005-2008, he was a postdoctoral associate with Prof. John F. Hartwig at Yale and later at UIUC. In 2009, he held a position of Research Investigator at GNF (the Genomics Institute of the Novartis Research Foundation). In September of 2012, he joined the Department of Pharmacology and Pharmaceutical Science, School of Medicine, Tsinghua University. Now Liao is a Professor in the School of Pharmaceutical Science, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University, where his researches focuses on three major areas: (1) bioactive natural-product-oriented synthesis and the development of new synthetic methods, (2) immuno-oncology projects related to T-cell exhaustion and innate immunity, and (3) structure-based drug discovery. He published over 50 peer reviewed papers in journals, Including Nature, Cancer Cell, Science Translational Medicine, JACS, Science Advance, Angew Chem Int Ed et al.

Xuebin Liao, Ph.D.

(Summary description)Scientific Founder in immunotherapy</br></br>
</br></br></br></br></br></br></br></br></br>

*****
Xuebin Liao obtained his B.S. degree from Peking University in 1995. Then he did his Ph.D work on natural product synthesis with Prof. James M. Cook at the University of Wisconsin at Milwaukee from 1998-2004. After that, from 2005-2008, he was a postdoctoral associate with Prof. John F. Hartwig at Yale and later at UIUC. In 2009, he held a position of Research Investigator at GNF (the Genomics Institute of the Novartis Research Foundation). In September of 2012, he joined the Department of Pharmacology and Pharmaceutical Science, School of Medicine, Tsinghua University. Now Liao is a Professor in the School of Pharmaceutical Science, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University, where his researches focuses on three major areas: (1) bioactive natural-product-oriented synthesis and the development of new synthetic methods, (2) immuno-oncology projects related to T-cell exhaustion and innate immunity, and (3) structure-based drug discovery. He published over 50 peer reviewed papers in journals, Including Nature, Cancer Cell, Science Translational Medicine, JACS, Science Advance, Angew Chem Int Ed et al.

Information